Astronics (US:ATRO)2026-02-26 19:31Sales and Market Segmentation - In 2025, sales in the Aerospace segment were divided as follows: 75% to the commercial transport market, 15% to the military aircraft market, 9% to the general aviation market, and 1% to other markets[18]. - Sales to Boeing accounted for 10.4% of total sales in 2025, down from 11.0% in 2023[20]. - Approximately 15% of consolidated sales in 2025 were made to U.S. government-related markets, indicating reliance on military spending[28]. - Sales to the commercial transport market totaled approximately $599.3 million, accounting for 69.5% of consolidated sales in 2025[170]. - The military aerospace market generated sales of approximately $116.3 million, representing 13.5% of consolidated sales in 2025[173]. - Sales to the general aviation market amounted to $69.8 million, which is about 8.1% of consolidated sales in 2025[175]. - The Test Systems segment accounted for approximately 7.5% of consolidated sales, totaling $64.8 million in 2025[177]. Financial Performance - Consolidated sales for 2025 were $862.1 million, an increase of $66.7 million or 8.4% compared to $795.4 million in 2024[188]. - Gross profit for 2025 was $258.2 million, resulting in a gross margin of 29.9%, up from 27.7% in 2024[188]. - Net income for 2025 was $29.4 million, or $0.81 per diluted share, compared to a net loss of $16.2 million, or $(0.46) per diluted share in 2024[196]. - The company incurred a net loss of $16.2 million and $26.4 million for the years ended December 31, 2024 and 2023, respectively, indicating ongoing financial challenges[88]. - Interest expense decreased by $9.4 million, or 42.9%, due to lower outstanding borrowings and reduced cost of debt[194]. Backlog and Bookings - The consolidated backlog as of December 31, 2025, was $674.5 million, an increase from $599.2 million in 2024, driven by recovering demand from commercial transport and general aviation customers[35]. - Bookings increased by 14.4% to $924.4 million, with a book-to-bill ratio of 1.07:1 in 2025[196]. - The backlog for the Aerospace segment was $600.8 million as of December 31, 2025, compared to $537.6 million in the previous year[206]. - The Test Systems segment backlog was $73.7 million as of December 31, 2025[36]. - Bookings for the Test Systems segment in 2025 were $76.8 million, resulting in a book-to-bill ratio of 1.19:1, with a backlog of $73.7 million at December 31, 2025, up from $61.7 million at December 31, 2024[211]. Acquisitions and Investments - The Company acquired Envoy Aerospace for approximately $8.3 million on June 30, 2025, and Bühler Motor Aviation for approximately $18.0 million on October 13, 2025[22][23]. - The company’s acquisition strategy involves risks that could adversely affect financial performance if expected benefits are not realized[66]. Operational Challenges and Risks - The commercial aerospace market is highly cyclical, with economic factors such as fuel prices and labor disputes directly affecting demand for new aircraft and upgrades, which could reduce sales and profits[56]. - The company is exposed to risks associated with government contracts, which represent a significant portion of its business, and funding is subject to annual congressional appropriations[60]. - The market for test systems products is concentrated with a limited number of significant customers, which may impair the ability to grow sales[58]. - New product development efforts may face difficulties, leading to potential reductions in sales and earnings if new products are not accepted by customers[65]. - Cybersecurity threats pose a significant risk, with potential impacts on sensitive information and business operations if successful attacks occur[69]. - The company must adapt to technological changes to remain competitive, as failure to do so may reduce demand for its products[64]. - A decline in government expenditures or changes in spending priorities could result in reduced volume of government contracts awarded to the company[62]. - The company has experienced significant price inflation in labor and materials, which has adversely affected its financial condition and may continue to do so[77]. - Supply chain constraints have led to increased material costs and potential delays in product delivery, adversely affecting growth and financial results[75]. - The company may face penalties for late deliveries due to various operational challenges, which could materially affect its financial condition[80]. - Regulatory compliance costs may increase due to new or more stringent governmental regulations, impacting operational expenses[86]. Legal and Compliance Issues - The company is currently involved in legal proceedings related to patent infringement, which could result in probable losses[73]. - In 2025, the company was ordered to pay $11.9 million in damages related to patent infringement, with additional amounts potentially payable based on ongoing appeals[107]. - The company is subject to extensive regulation and audit by the Defense Contract Audit Agency, which could result in adjustments to contract costs and profitability[118]. - The company faces reputational, regulatory, and financial risks related to sustainability goals, which may require costly initiatives to meet evolving criteria[117]. Debt and Financial Structure - The Company entered into a $300.0 million senior secured revolving credit facility on October 22, 2025, replacing a previous $220.0 million facility[30]. - As of December 31, 2025, the company had approximately $343.0 million of debt outstanding, which could adversely affect operational and financial flexibility[96]. - The conditional conversion feature of the Convertible Notes may adversely affect financial condition and operating results, potentially impacting liquidity[94]. - The company’s ability to repurchase Convertible Notes or pay cash upon conversion may be limited by law or agreements governing future indebtedness, constituting a default risk[93]. Employee and Shareholder Information - As of December 31, 2025, the Company employed approximately 2,700 full-time employees, with about 2,100 in the U.S.[39]. - The company has a total of 1,588 shareholders of record for Common Stock as of February 19, 2026[142]. - The company has not paid any cash dividends in the three-year period ended December 31, 2025, and plans to retain all cash from operations for capital needs[143]. Stock Performance - The company's stock price ranged from a low of $15.60 to a high of $55.71 for the year ended December 31, 2025, indicating significant volatility[124]. - Astronics Corporation's cumulative total return on common shares increased by 69.10% in 2023, with a cumulative value of $131.64 from an initial investment of $100[147].